WilmerHale provides legal representation across a comprehensive range of practice areas critical to the success of its clients. With a staunch commitment to public service, the firm is a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia.
Life sciences companies (particularly early stage companies) may be attracted to an LLC holding company structure as an alternative to a typical C corporation structure to maximize both...
United StatesFood, Drugs, Healthcare, Life Sciences
Life sciences companies (particularly early stage companies) may
be attracted to an LLC holding company structure as an alternative
to a typical C corporation structure to maximize both the purchase
price paid by a future acquiror of a drug development program and
the after-tax proceeds realized by the company's investors upon
a sale. View a description of the LLC holding company structure and its pros and
cons.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
